There are 2789 resources available
969P - Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
Presenter: Patricia Pereira
Session: ePoster Display
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display
971P - Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Presenter: Thierry Landre
Session: ePoster Display
871P - Uptake of concurrent chemoradiation in stage 2 nasopharyngeal cancer (NPC): A population-based outcomes study
Presenter: Teng Hwee Tan
Session: ePoster Display
872P - Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Christopher Black
Session: ePoster Display
873P - Early efficacy prediction of nasopharyngeal carcinoma based on 3D-ADC acquired during radiotherapy: A phase II prospective study
Presenter: Mei Feng
Session: ePoster Display
874P - Concurrent chemoradiation with cisplatin alone versus cisplatin and capecitabine in treatment of locally advanced head and neck cancer
Presenter: Abhishek Krishna
Session: ePoster Display
Resources:
Abstract
870P - Comparison of PD-L1 and VISTA expression levels in head and neck cancers in primary and recurrent tumor tissue after radiotherapy/chemoradiotherapy
Presenter: Görkem Yazıcı Şener
Session: ePoster Display
973P - A phase II study of PDR001 among patients with recurrent and/or metastatic esophageal squamous cell carcinoma: An interim analysis of KM-12
Presenter: Dong Ki Lee
Session: ePoster Display